161 related articles for article (PubMed ID: 10975396)
1. Serum BCL2/IGH DNA in follicular lymphoma patients: a minimal residual disease marker.
Gocke CD; Kopreski MS; Benko FA; Sternas L; Kwak LW
Leuk Lymphoma; 2000 Sep; 39(1-2):165-72. PubMed ID: 10975396
[TBL] [Abstract][Full Text] [Related]
2. Detection of t(14;18) by PCR of IgH/BCL2 fusion gene in follicular lymphoma from archived cytological smears.
Stoos-Veić T; Livun A; Ajduković R; Pejsa V; Jaksić O; Kusec R
Coll Antropol; 2010 Jun; 34(2):425-9. PubMed ID: 20698113
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis between RQ-PCR and digital droplet PCR of BCL2/IGH gene rearrangement in the peripheral blood and bone marrow of early stage follicular lymphoma.
Cavalli M; De Novi LA; Della Starza I; Cappelli LV; Nunes V; Pulsoni A; Del Giudice I; Guarini A; Foà R
Br J Haematol; 2017 May; 177(4):588-596. PubMed ID: 28419517
[TBL] [Abstract][Full Text] [Related]
4. Common consensus LNA probe for quantitative PCR assays in cancer: vehicles for minimal residual disease detection in t(11;14) and t(14;18) positive malignant lymphomas.
Sørensen CD; Jørgensen JM; Nederby L; Hokland P; Nyvold CG
J Immunol Methods; 2014 Apr; 406():131-6. PubMed ID: 24631717
[TBL] [Abstract][Full Text] [Related]
5. Novel bcl-2 breakpoints in patients with follicular lymphoma.
Wang YL; Addya K; Edwards RH; Rennert H; Dodson L; Leonard DG; Wilson RB
Diagn Mol Pathol; 1998 Apr; 7(2):85-9. PubMed ID: 9785006
[TBL] [Abstract][Full Text] [Related]
6. MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR.
Pott C; Brüggemann M; Ritgen M; van der Velden VH; van Dongen JJ; Kneba M
Methods Mol Biol; 2013; 971():175-200. PubMed ID: 23296964
[TBL] [Abstract][Full Text] [Related]
7. Translocation t(14;18)/IGH-BCL2 in gastrointestinal follicular lymphoma: correlation with clinicopathologic features in 48 patients.
Yanai S; Nakamura S; Takeshita M; Fujita K; Hirahashi M; Kawasaki K; Kurahara K; Sakai Y; Matsumoto T
Cancer; 2011 Jun; 117(11):2467-77. PubMed ID: 24048795
[TBL] [Abstract][Full Text] [Related]
8. Detection of clonal CD34+19+ progenitors in bone marrow of BCL2-IgH-positive follicular lymphoma patients.
Macintyre EA; Belanger C; Debert C; Canioni D; Turhan AG; Azagury M; Hermine O; Varet B; Flandrin G; Schmitt C
Blood; 1995 Dec; 86(12):4691-8. PubMed ID: 8541563
[TBL] [Abstract][Full Text] [Related]
9. Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma.
Genuardi E; Klous P; Mantoan B; Drandi D; Ferrante M; Cavallo F; Alessandria B; Dogliotti I; Grimaldi D; Ragaini S; Clerico M; Lo Schirico M; Saraci E; Yilmaz M; Zaccaria GM; Cortelazzo S; Vitolo U; Luminari S; Federico M; Boccadoro M; van Min M; Splinter E; Ladetto M; Ferrero S
Hematol Oncol; 2021 Aug; 39(3):293-303. PubMed ID: 33742718
[TBL] [Abstract][Full Text] [Related]
10. Polymerase chain reaction based gene rearrangement studies in the diagnosis of follicular lymphoma--performance in formaldehyde-fixed tissue and application in clinical problem cases.
Miettinen M; Lasota J
Pathol Res Pract; 1997; 193(1):9-19. PubMed ID: 9112269
[TBL] [Abstract][Full Text] [Related]
11. Incidence and clinical significance of bcl-2/IgH rearrangements in follicular lymphoma.
Montoto S; López-Guillermo A; Colomer D; Esteve J; Bosch F; Ferrer A; Villamor N; Moreno C; Campo E; Montserrat E
Leuk Lymphoma; 2003 Jan; 44(1):71-6. PubMed ID: 12691144
[TBL] [Abstract][Full Text] [Related]
12. Molecular-cytogenetic characterization of non-Hodgkin's lymphoma with double and cryptic translocations of the immunoglobulin heavy chain gene.
Kanda-Akano Y; Nomura K; Fujita Y; Horiike S; Nishida K; Nagai M; Miura I; Nakamura S; Seto M; Iida S; Ueda R; Taniwaki M
Leuk Lymphoma; 2004 Aug; 45(8):1559-67. PubMed ID: 15370207
[TBL] [Abstract][Full Text] [Related]
13. [Follicular lymphomas: molecular diagnosis using t(14;18)(q32;q21)--fluorescence in situ hybridization, qualitative and quantitative PCR].
Mrhalová M; Krsková L; Kalinová M; Soukup J; Kodet R
Cesk Patol; 2003 Jul; 39(3):130-7. PubMed ID: 14631811
[TBL] [Abstract][Full Text] [Related]
14. FISH is better than BIOMED-2 PCR to detect IgH/BCL2 translocation in follicular lymphoma at diagnosis using paraffin-embedded tissue sections.
Espinet B; Bellosillo B; Melero C; Vela MC; Pedro C; Salido M; Pijuan L; Florensa L; Besses C; Serrano S; Solé F
Leuk Res; 2008 May; 32(5):737-42. PubMed ID: 17964648
[TBL] [Abstract][Full Text] [Related]
15. The bcl-2/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity.
Schmitt C; Balogh B; Grundt A; Buchholtz C; Leo A; Benner A; Hensel M; Ho AD; Leo E
Leuk Res; 2006 Jun; 30(6):745-50. PubMed ID: 16297448
[TBL] [Abstract][Full Text] [Related]
16. Occult lymphoma cells prevalent in autologous marrow from non-Hodgkin's diffuse lymphoma.
Yokoyama J; Fujimiya Y; Yamaguchi T; Shiga K; Saijo Y; Groveman DS; McBain JA; Suzuki Y; Ebina T
Am J Hematol; 2003 May; 73(1):1-11. PubMed ID: 12701113
[TBL] [Abstract][Full Text] [Related]
17. Droplet Digital PCR for Minimal Residual Disease Detection in Mature Lymphoproliferative Disorders.
Drandi D; Ferrero S; Ladetto M
Methods Mol Biol; 2018; 1768():229-256. PubMed ID: 29717447
[TBL] [Abstract][Full Text] [Related]
18. Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center B cells.
Fenton JA; Vaandrager JW; Aarts WM; Bende RJ; Heering K; van Dijk M; Morgan G; van Noesel CJ; Schuuring E; Kluin PM
Blood; 2002 Jan; 99(2):716-8. PubMed ID: 11781262
[TBL] [Abstract][Full Text] [Related]
19. Frequency of BCL-2/J(H) translocations in peripheral blood of follicular lymphoma patients.
Zhang XY; Safah H; Mudad R; Maher E; Krause J; Miller A; Ehrlich M
Am J Hematol; 1997 Aug; 55(4):205-7. PubMed ID: 9257881
[TBL] [Abstract][Full Text] [Related]
20. A real-time (PCR) for a real life…? Quantitative evaluation of BCL2/IGH in follicular lymphoma and its implications for clinical practice.
Janikova A; Mareckova A; Dvorakova D; Bortlicek Z; Tichy B; Navratil M; Kral Z; Pospisilova S; Mayer J
Exp Hematol; 2012 Jul; 40(7):528-539.e4. PubMed ID: 22381682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]